Add to Favorites Newsroom RSS Share
Madison, WI USA

Our News on Newswise

ACTRIMS Recognizes Young Investigators at Forum 2017

Abstracts from Environmental Factors, Genetics and Epigenetics in MS Susceptibility and Clinical Course are now available at Multiple Sclerosis Journal.
9-Mar-2017 10:05 AM EST Add to Favorites

Environmental Factors, Genetics and Epigenetics Is Focus of Multiple Sclerosis Forum

The second annual ACTRIMS Forum gets underway today. This year, the forum was preceded by the Neurology Resident Summit in Neuroimmunology, which drew 47 residents from the United States and Canada.
23-Feb-2017 3:05 PM EST Add to Favorites

New Understanding of Autoimmune Function in MS Is Described as a Breakthrough

A new, highly effective multiple sclerosis therapy will be presented at the America’s Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2017, Thursday, Feb. 23, in Orlando.
20-Dec-2016 4:05 PM EST Add to Favorites

Americas Committee for Treatment and Research in Multiple Sclerosis Announces 2017 Forum

2017logo.png

Environmental factors, genetics and epigenetics in multiple sclerosis susceptibility and clinical course is focus of ACTRIMS Forum 2017.
1-Aug-2016 11:05 AM EDT Add to Favorites

Late-Breaking Research Shows Promise for Patients with Primary Progressive Multiple Sclerosis

Abstract describes efficacy of ocrelizumab in patients with PPMS with and without T1 gadolinium-enhancing lesions at baseline in a Phase III, placebo-controlled trial.
26-Feb-2016 11:05 AM EST Add to Favorites

ACTRIMS 2016 Concludes With Young Investigator Awards

Opportunities for young investigators to present their findings and consult with established researchers and clinicians were among the primary goals of ACTRIMS Forum 2016. The event drew more than 600 participants to New Orleans.
23-Feb-2016 5:05 PM EST Add to Favorites

North America’s Leading MS Experts Meet in New Orleans

More than 500 clinicians and researchers are meeting in New Orleans to share the latest information about progressive multiple sclerosis.
18-Feb-2016 7:05 PM EST Add to Favorites

Late-Breaking Abstracts From ACTRIMS 2016 Now Available

Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? Roberta Magliozzi, Ph.D., Imperial College, London, UK
18-Feb-2016 10:05 AM EST Add to Favorites

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!